Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measurement of Iodolipids in the Thyroid Gland (IODOLIP)
NCT05628506Not yet recruiting
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of Potassium iodide in thyroid nodule and Non-toxic multinodular goiter (2 arms). Primary endpoints: 2-iodoxehadecanal at 20 hours and delta-iodolactone at 20 hours. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
Potassium iodide
03
Conditions
thyroid noduleNon-toxic multinodular goiter
Beyond the preview
Go deeper on NCT05628506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05628506.